PCH
Polar Capital Holdings’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.5M | Buy |
2,798,401
+342,664
| +14% | +$11.3M | 0.48% | 56 |
|
|
2025
Q1 | $98.7M | Buy |
2,455,737
+259,016
| +12% | +$10.4M | 0.6% | 47 |
|
|
2024
Q4 | $103M | Sell |
2,196,721
-141,126
| -6% | -$6.64M | 0.58% | 49 |
|
|
2024
Q3 | $123M | Sell |
2,337,847
-116,818
| -5% | -$6.17M | 0.59% | 38 |
|
|
2024
Q2 | $133M | Buy |
2,454,665
+849,089
| +53% | +$46M | 0.78% | 33 |
|
|
2024
Q1 | $113M | Buy |
1,605,576
+188,522
| +13% | +$13.2M | 0.59% | 41 |
|
|
2023
Q4 | $118M | Sell |
1,417,054
-1,237,391
| -47% | -$103M | 0.72% | 32 |
|
|
2023
Q3 | $78.2M | Hold |
2,654,445
| – | – | 0.58% | 50 |
|
|
2023
Q2 | $86.6M | Buy |
2,654,445
+42,753
| +2% | +$1.39M | 0.44% | 51 |
|
|
2023
Q1 | $91.9M | Sell |
2,611,692
-113,085
| -4% | -$3.98M | 0.6% | 44 |
|
|
2022
Q4 | $125M | Buy |
2,724,777
+53,129
| +2% | +$2.43M | 1% | 21 |
|
|
2022
Q3 | $129K | Sell |
2,671,648
-355,000
| -12% | -$17.2K | 0.82% | 20 |
|
|
2022
Q2 | $119K | Sell |
3,026,648
-154,652
| -5% | -$6.08K | 0.7% | 26 |
|
|
2022
Q1 | $117K | Sell |
3,181,300
-490,669
| -13% | -$18.1K | 0.53% | 35 |
|
|
2021
Q4 | $167K | Buy |
3,671,969
+657,087
| +22% | +$30K | 0.63% | 27 |
|
|
2021
Q3 | $108K | Buy |
3,014,882
+585,782
| +24% | +$20.9K | 0.44% | 42 |
|
|
2021
Q2 | $48.1K | Sell |
2,429,100
-242,784
| -9% | -$4.81K | 0.21% | 105 |
|
|
2021
Q1 | $62.1M | Sell |
2,671,884
-600,000
| -18% | -$14M | 0.38% | 76 |
|
|
2020
Q4 | $68M | Buy |
+3,271,884
| New | +$68M | 0.41% | 69 |
|